The authorization will let the Pune-based Serum Institute of India supply Oxford-AstraZeneca Covid-19 vaccine Covishield to the WHO-backed COVAX initiative. On Monday, the World Health Organization (WHO) granted emergency use listing (EUL) for the Oxford-AstraZeneca Covid-19 vaccine manufactured by India's...
Serum Institute of India (SII) CEO Adar Poonawalla on Saturday said that the company hopes to launch the Covid-19 vaccine in partnership with US-based biotech company Novavax called Covovax in India by June 2021. Poonawalla tweeted: “Our partnership for a...
India approved two Covid-19 vaccines AstraZeneca-Oxford University’s Covishield and Bharat Biotech’s Covaxin on Sunday. India set out on an ambitious journey on Monday by undertaking what Prime Minister Modi called the world’s largest mass immunization program. The mammoth effort follows...
